The SynCardia temporary total artificial heart-evolving clinical role and future status

US Cardiology

Volumn 8, Issue 1, 2011, Pages 39-46

  Slepian, Marvin J ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Blood flow; Cardiac transplantation; Heart failure; Mechanical circulatory support; Pulsatility; Total artificial heart

Indexed keywords

ARTICLE; ARTIFICIAL HEART; ASSISTED CIRCULATION; ASSISTIVE TECHNOLOGY; CLINICAL EFFECTIVENESS; CORONARY ARTERY BLOOD FLOW; DEVICE SAFETY; EQUIPMENT DESIGN; HEART ASSIST DEVICE; HEART HEMODYNAMICS; HEART TRANSPLANTATION; HEART VENTRICLE FAILURE; HUMAN; INSTRUMENT VALIDATION; OVERALL SURVIVAL; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; SURVIVAL RATE; TREATMENT INDICATION;

EID: 79956337203     PISSN: 17583896     EISSN: 1758390X     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Heart Disease and Stroke Statistics - 2010 Update, Circulation, 2010;121:e46-215.
2. Syncardia Temporary CardioWest Total Artificial Heart (TAH-t) - P030011, FDA Approval order, Issued October 15, 2004, www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfTopic/pma/pma.cfm?num=p030011 (accessed February 17, 2011).
3. Artificial Heart Clinical Study Approvals, www.cms.gov/MedicareApprovedFacilitie/06_artificialhearts.asp (accessed February 17, 2011).
4. Copeland JG, Arabia FA, Tsau PH, et al., Total artificial hearts: bridge to transplantation, Cardiol Clinics, 2003;21:101-13.
5. Copeland JG, Smith RG, Arabia FA, et al., CardioWest Total Artificial Heart Investigators, Cardiac replacement with a total artificial heart as a bridge to transplantation, New Engl J Med, 2004;351(9):859-67.
6. Miller LW, Pagani FD, Russell SD, et al., for the HeartMate II Clinical Investigators, Use of a continuous-flow device in pateints awaiting heart transplantation, N Engl J Med, 2007;357:885-96.
7. Ku DN, Blood flow in arteries, Ann Rev Fluid Mech, 1997;29:399-434.
8. Younis BA, Berger SA, A turbulence model for pulsatile arterial blood flows, J Biomech Eng, 2004;126:578-84.
9. Loebe M, Koster A, Sänger S, et al., Inflammatory response after implantation of a left ventricular assist device: comparison between the axial flow MicroMed DeBakey VAD and the pulsatile Novacor Device, ASAIO Journal, 2001;47:272-4.
10. John R, Panch S, Hrabe J, et al., Activation of endothelial and coagulation systems in left ventricular assist device recipients, Ann Thoracic Surg, 2009;88:1171-9.
11. Nakano T, Tominaga R, Morita S, et al., Impacts of pulsatile systemic circulation on endothelium-derived nitric oxide release in anesthetized dogs, Ann Thorac Surg, 2001;72:156-62.
12. Uriel N, Pak SW, Jorde UP, et al., Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation, J Am Coll Cardiol, 2010;56:1207-13.
13. Heilmann C, Geisen U, Beyersdorf F, et al., Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart, Thromb Haemost, 2010;103(5):962-7.
14. Cowger J, Pagani FD, Haft JW, et al., The development of aortic insufficiency in left ventricular assist device-supported patients, Circ Heart Fail, 2010;3:668-74.
15. Di Bella I, Pagani F, Banfi C, et al., Results with the Novacor Assist System and evaluation of long-term assistance, European J Cardio Thoracic Surg, 2000;18:112-6.
16. Frazier OH, Rose EA, Oz MC, et al., for the HeartMate LVAS Investigators, Multi-center clinical evaluation of the Heartmate vented electric left ventricular assist system in patients awaiting heart transplantation, J Thorac Cardiovasc Surg, 2001;122:1186-95.
17. Slaughter MS, Rogers JG, Milano CA, et al., for the HeartMate II Investigators, Advanced heart failure treated with continuousflow left ventricular assist device, N Engl J Med, 2009;361:2241-51.
18. Copeland JG, Smith RG, Arabia FA, et al., Total artificial heart bridge to transplantation: a 9-year experience with 62 patients, J Heart Lung Transplant, 2004;23:823-31.
19. Leprince P, Bonnet N, Rama A, et al., Bridge to transplantation with the Jarvik-7 (CardioWest) total artificial heart: a single center 15-year experience, J Heart Lung Transplant, 2003;22:1296-303.
20. 2001 Annual report of the U.S. Organ Procurement and Transplantation Network and the scientific Registry of Transplantation Recipients, Vol. 1, Washington, DC: Department of Health and Human Services, 2001:439-83.
21. INTERMACS Quarterly Statistical Report, #HHSN268200548198C, issued 7/23/2010. Available at: www.uab.edu/ctsresearch/intermacs/statisticalsummaries.htm (accessed February 17, 2011).
22. Intermacs Selected PowerPoint Slides, issued 3/31/09, www.uab.edu/ctsresearch/intermacs/statisticalsummaries.htm (accessed February 17, 2011).
23. Syncardia Total Artificial Heart - Indication for use, www.fda.gov/ohrms/dockets/ac/04/briefing/4029b1_final.pdf (accessed February 17, 2011).
24. Slepian MJ, Copeland JC, The Total Artificial Heart in refractory cardiogenic shock: saving the patient versus saving the heart, Nat Clin Prac Cardiovasc Med, 2008;5:64-5.
25. 2 have a good outcome with the CardioWest Total Artificial Heart, J Heart Lung Transplant, 2005;24:1501-5.
26. Dang NC, Topkara VK, Mercando M, et al., Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure, J Heart Lung Transplant, 2006;25:1-6.
27. Oz MC, Goldstein DJ, Pepino P, et al., Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices, Circulation, 1995;92:169-73.
28. Farrar DJ, Preoperative predictors of survival in patients with Thoratec ventricular assist devices as a bridge to heart transplantation. Thoratec Ventricular Assist Device Principal Investigators, J Heart Lung Transplant, 1994;13:93-101.
29. Copeland JG, Smith RG, Bose RK, et al., Risk factor analysis for bridge to transplantation with the CardioWest total artificial heart, Ann Thorac Surg, 2008;85:1639-44.
30. Leshnower BG, Smith RG, O'Hara ML, et al., Is the Total Artificial Heart Superior to BIVAD Therapy as a Method of Bridging Patients to Heart Transplantation? 43rd Annual meeting of the Society of Thoracic Surgeons, San Diego, CA, January 2007.
31. Roger VL, The heart failure epidemic, Int J Environ Res Public Health, 2010;7:1807-30.